Breakthrough can boost lab test’s sensitivityJune 4th, 2012 - 2:14 pm ICT by IANS
Washington, June 4 (IANS) A breakthrough in nanotechnology would boost a lab test’s sensitivity more than three-million-fold, vastly improving early detection of cancer, Alzheimer’s disease and other disorders, a study reveals.
It involves a common biological test called an immunoassay, which mimics the action of the immune system to detect the presence of biomarkers - the chemicals linked with diseases.
It would enable doctors to detect the lowest ever concentrations of telltale markers than was previously practical, the journals Nanotechnology and Analytical Chemistry reported.
Simply stated, the immunoassay would require three million times fewer biomarkers to be present compared to an existing conventional immunoassay.
“This advance opens many new and exciting opportunities for immunoassays and other detectors, as well as in disease early detection and treatment,” said Stephen Chou, professor of engineering at Princeton, who led the research team.
“Furthermore, the new assay is very easy to use, since for the person conducting the test, there will be no difference from the old one - they do the procedure in exactly the same way,” added Chou, according to a university statement.
When biomarkers are present in samples, such as those taken from humans, the immunoassay test produces a fluorescent glow (light) that can be measured in a lab. The greater the glow, the more of the biomarker is present.
However, if the amount of biomarker is too small, the fluorescent light is too faint to be detected, setting the limit of detection.
Princeton University researchers tackled this limitation by using nanotechnology to greatly amplify the faint fluorescence from a sample.
By fashioning glass and gold structures so small they could only be seen with a powerful electron microscope, scientists were able to drastically increase the fluorescence signal compared to conventional immunoassays, leading to a three-million-fold improvement in the limit of detection.
That is, the enhanced immunoassay would require three million times fewer biomarkers to be present compared to a conventional immunoassay.
- Groundbreaking technology to detect Alzheimer's developed - Jan 07, 2011
- Electronic Nose can sniff tuberculosis - Nov 06, 2011
- Chandigarh lab, northeast varsity work on cancer detector - Dec 01, 2011
- Ultra-sensitive sensor to help detect cancer signs, hidden explosives - Mar 22, 2011
- Rust and sand could help detect cervical cancer, diarrhoea - Feb 01, 2011
- Biomarker can nip hardening of arteries in the bud - Jan 22, 2012
- From IIT-M, nano-scale device to detect big explosives - Aug 28, 2012
- Now, a dog that glows in the dark - Jul 30, 2011
- New test can quickly distinguish infection from tuberculosis disease - Apr 02, 2011
- Biosensor detects sexually transmitted disease in a jiffy - May 11, 2009
- Age of nanomedicine: microchip to detect cancers, other diseases (Lead) - Sep 30, 2009
- Four novel biomarkers that may help diagnose asthma, COPD identified - Mar 12, 2011
- New chip can detect cancer early - Sep 30, 2009
- Researchers create a living neon sign - Dec 20, 2011
- Cheap, fast test identifies aggressive type of lung cancer in never-smokers - Feb 26, 2011
Tags: alzheimer, analytical chemistry, biomarker, breakthrough, cancer, chemicals, diseases, doctors, electron microscope, glow light, immune system, immunoassay, journals, lab test, million times, nanotechnology, presence, princeton university researchers, scientists, stephen chou